Tolerance Induction and Endogenous Regeneration of Pancreatic Beta-cells in Established Autoimmune Diabetes

Overview

Journal Rev Diabet Stud

Specialty Endocrinology

Date 2007 May 12

PMID 17491705

Authors

Charles Sia

Francoise Homo-Delarche

Affiliations

Soon will be listed here.

Abstract

Studies aimed at the understanding of the multifactorial development of autoimmune diabetes have made substantial contributions toward elucidating the molecular mechanisms that open the road to an effective prevention of defective immune responses. Immunomodulatory regimens capable of inducing tolerance are shown to be effective even in the reversal of established autoimmune diabetes in animal models. Experimental trials including the reeducation of autoreactive T cells, depletion of macrophages, dendritic cells, and T cells, as well as the use of monoclonal antibodies, have yielded encouraging results, but have not yet been translated into beneficial clinical outcomes. In addition, we are now seeing an emergence of promising new directions aimed at the induction of islet regeneration by endogenous factors, suggesting that the repair of pancreatic tissue is possible without the need for an engraftment of donor tissue. These recent waves of technological progress have injected new hope for a combined therapy to offer diabetic patients long-term benefits of insulin independence. This article reviews the latest findings on diabetic pathogenesis and discusses promising avenues to tolerance induction and islet regeneration.

References

Robertson R, Sutherland D, Kendall D, Teuscher A, Gruessner R, Gruessner A . Metabolic characterization of long-term successful pancreas transplants in type I diabetes. J Investig Med. 1996; 44(9):549-55. View

von Herrath M, Homann D . Islet regeneration needed for overcoming autoimmune destruction - considerations on the pathogenesis of type 1 diabetes. Pediatr Diabetes. 2004; 5 Suppl 2:23-8. DOI: 10.1111/j.1399-543X.2004.00076.x. View

Arreaza G, Salojin K, Yang W, Zhang J, Gill B, Mi Q . Deficient activation and resistance to activation-induced apoptosis of CD8+ T cells is associated with defective peripheral tolerance in nonobese diabetic mice. Clin Immunol. 2003; 107(2):103-15. DOI: 10.1016/s1521-6616(03)00049-4. View

Dharnidharka V, Van Patten Y, Bahjat F, Clare-Salzler M . Fas stimulation results in selective islet infiltrate apoptosis in situ and reversal of diabetes. Ann N Y Acad Sci. 2002; 958:160-2. DOI: 10.1111/j.1749-6632.2002.tb02960.x. View

Krapp A, Knofler M, Ledermann B, Burki K, Berney C, Zoerkler N . The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev. 1998; 12(23):3752-63. PMC: 317250. DOI: 10.1101/gad.12.23.3752. View

Hashimoto Y, Maxam A, Greene M . T-cell antigen-receptor genes in autoimmune mice. Proc Natl Acad Sci U S A. 1986; 83(20):7865-9. PMC: 386823. DOI: 10.1073/pnas.83.20.7865. View

Pestano G, Zhou Y, Trimble L, Daley J, Weber G, CANTOR H . Inactivation of misselected CD8 T cells by CD8 gene methylation and cell death. Science. 1999; 284(5417):1187-91. DOI: 10.1126/science.284.5417.1187. View

Kodama S, Kuhtreiber W, Fujimura S, Dale E, Faustman D . Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science. 2003; 302(5648):1223-7. DOI: 10.1126/science.1088949. View

Hanninen A, Harrison L . Mucosal tolerance to prevent type 1 diabetes: can the outcome be improved in humans?. Rev Diabet Stud. 2007; 1(3):113-21. PMC: 1783546. DOI: 10.1900/RDS.2004.1.113. View

10.

Huang F, MacPherson G . Continuing education of the immune system--dendritic cells, immune regulation and tolerance. Curr Mol Med. 2002; 1(4):457-68. DOI: 10.2174/1566524013363573. View

11.

Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka T . Involvement of oxidative stress and the JNK pathway in glucose toxicity. Rev Diabet Stud. 2007; 1(4):165-74. PMC: 1783693. DOI: 10.1900/RDS.2004.1.165. View

12.

Yoon J, Jun H . Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus. Ann N Y Acad Sci. 2002; 928:200-11. DOI: 10.1111/j.1749-6632.2001.tb05650.x. View

13.

Mountz J, Bluethmann H, Zhou T, Wu J . Defective clonal deletion and anergy induction in TCR transgenic lpr/lpr mice. Semin Immunol. 1994; 6(1):27-37. DOI: 10.1006/smim.1994.1005. View

14.

Feili-Hariri M, Falkner D, Morel P . Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice. Eur J Immunol. 2002; 32(7):2021-30. DOI: 10.1002/1521-4141(200207)32:7<2021::AID-IMMU2021>3.0.CO;2-J. View

15.

Rosmalen J, van Ewijk W, Leenen P . T-cell education in autoimmune diabetes: teachers and students. Trends Immunol. 2002; 23(1):40-6. DOI: 10.1016/s1471-4906(01)02088-9. View

16.

Martinez N, Augstein P, Moustakas A, Papadopoulos G, Gregori S, Adorini L . Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J Clin Invest. 2003; 111(9):1365-71. PMC: 154446. DOI: 10.1172/JCI17166. View

17.

Atkinson M, Leiter E . The NOD mouse model of type 1 diabetes: as good as it gets?. Nat Med. 1999; 5(6):601-4. DOI: 10.1038/9442. View

18.

Trofe J, Beebe T, Buell J, Hanaway M, First M, Alloway R . Posttransplant malignancy. Prog Transplant. 2004; 14(3):193-200. DOI: 10.1177/152692480401400304. View

19.

Hayashi T, Faustman D . NOD mice are defective in proteasome production and activation of NF-kappaB. Mol Cell Biol. 1999; 19(12):8646-59. PMC: 85003. DOI: 10.1128/MCB.19.12.8646. View

20.

Kodama S, Faustman D . Routes to regenerating islet cells: stem cells and other biological therapies for type 1 diabetes. Pediatr Diabetes. 2004; 5 Suppl 2:38-44. DOI: 10.1111/j.1399-543X.2004.00078.x. View